The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Regeneron
Consulting or Advisory Role - Regeneron
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celldex; Genentech; Merck; Novartis; Regeneron
Travel, Accommodations, Expenses - Regeneron
Treatment patterns and outcomes among patients with advanced cutaneous squamous cell carcinoma (CSCC) in a US community oncology setting.
 
C. Lance Cowey
No Relationships to Disclose
 
Nicholas J. Robert
Employment - McKesson
Leadership - McKesson
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; New Century Health
Research Funding - Side-Out Foundation (Inst)
 
Kalatu Davies
Employment - McKesson
 
Janet L. Espirito
Employment - McKesson
Stock and Other Ownership Interests - McKesson
 
Jennifer R. Frytak
Employment - McKesson
Stock and Other Ownership Interests - McKesson
Travel, Accommodations, Expenses - Bristol-Myers Squibb
 
Israel Lowy
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Consulting or Advisory Role - Egenix
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)